CoChat

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

Open access
Cardoso, C. R. L., Leite, N. C., Moram, C. B. M., Salles, G. F. · 2018 · Cardiovascular Diabetology

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Long-term visit-to-visit glycemic variability is an additional measure of glycemic control. We aimed to evaluate the prognostic value of several measures of glycemic variability for the occurrence of micro- and macrovascular complications, and all-cause mortality in patients with type 2 diabetes. 654 individuals were followed-up over a median of 9.3 years. Glycemic variability (SDs and coefficients of variation of HbA 1c and fasting glycaemia) was measured during the first 12- and 24-months. Multivariate Cox analysis, adjusted for risk factors and mean HbA 1c and fasting glycaemia levels, examined the associations between glycemic variability and the occurrence of microvascular (retinopathy, microalbuminuria, renal function deterioration, peripheral neuropathy) and macrovascular complications [total cardiovascular events (CVE), major adverse CVEs (MACE) and cardiovascular mortality], and of all-cause mortality. During follow-up, 128 patients had a CVE (96 MACE), and 158 patients died (67 from cardiovascular diseases); 152 newly-developed or worsened diabetic retinopathy, 183 achieved the renal composite outcome (89 newly developed microalbuminuria and 91 deteriorated renal function), and 96 newly-developed or worsened peripheral neuropathy. Glycemic variability, particularly the 24-month parameters either estimated by HbA 1c or by fasting glycemia, predicted all endpoints, except for retinopathy and peripheral neuropathy development/progression, and was a better predictor than mean HbA 1c . Glycemic variability predicted retinopathy development/progression in patients with good glycemic control (HbA 1c ≤ 7.5%, 58 mmol/mol) and predicted new-incident peripheral neuropathy. Long-term visit-to-visit glycemic variability is an additional and frequently a better glycemic parameter than mean HbA 1c levels for assessing the risk of future development of micro- and macrovascular complications in patients with type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-018-0677-0

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Kaplan-Meier estimates of cumulative incidence of total cardiovascular events (a, b), major cardiovascular events (MACE, c, d), cardiovascular deaths (e, f) and all-cause deaths (g, h) during follow-up in patients categorized into tertiles (green curve first tertile, blue curve second tertile, and red curve third tertile) of 24-month fasting glycemia standard deviation (upper panels a, c, e and g) and HbA1c standard deviation (lower panels b, d, f and h)
Fig. 1 Kaplan-Meier estimates of cumulative incidence of total cardiovascular events (a, b), major cardiovascular events (MACE, c, d), cardiovascular deaths (e, f) and all-cause deaths (g, h) during follow-up in patients categorized into tertiles (green curve first tertile, blue curve second tertile, and red curve third tertile) of 24-month fasting glycemia standard deviation (upper panels a, c, e and g) and HbA1c standard deviation (lower panels b, d, f and h)CC BY · PubMed Central
Fig. 2 Kaplan–Meier estimates of cumulative diabetic retinopathy incidence or worsening (a, b), composite renal events (microalbuminuria and renal function deterioration, c, d), microalbuminuria incidence (e, f) and renal function deterioration (g, h) during follow-up in patients categorized into tertiles (green curve first tertile, blue curve second tertile, and red curve third tertile) of 24-month fasting glycemia standard deviation (upper panels a, c, e and g) and of 24-month HbA1c standard deviation (lower panels b, d, f and h)
Fig. 2 Kaplan–Meier estimates of cumulative diabetic retinopathy incidence or worsening (a, b), composite renal events (microalbuminuria and renal function deterioration, c, d), microalbuminuria incidence (e, f) and renal function deterioration (g, h) during follow-up in patients categorized into tertiles (green curve first tertile, blue curve second tertile, and red curve third tertile) of 24-month fasting glycemia standard deviation (upper panels a, c, e and g) and of 24-month HbA1c standard deviation (lower panels b, d, f and h)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 224

Metadata

Authors
Cardoso, C. R. L., Leite, N. C., Moram, C. B. M., & Salles, G. F.
Affiliations
Universidade Federal do Rio de Janeiro (BR)
Corresponding author
Salles, G. F.
Venue
Cardiovascular Diabetology
Published
2018-02-24
Volume
17
Issue
1
Pages
33-33
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2804490349
Cited by
222
References
67
Citations by year
2026: 7 · 2025: 17 · 2024: 55 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 38 · 2019: 23 · 2018: 8
FWCI
18.51
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
glycemic variability, type 2 diabetes, microvascular complications, macrovascular complications, HbA1c, fasting blood glucose, diabetic retinopathy, microalbuminuria, diabetic nephropathy, peripheral neuropathy, cardiovascular events, major adverse cardiovascular events, cardiovascular mortality, all-cause mortality, prognostic factors, glycemic control
MeSH terms
Aged, Albuminuria, Blood Glucose, Brazil, Cause of Death, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Disease Progression, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. https://app.cochat.ai/papers/10.1186/s12933-018-0677-0
The paper
Cardoso, C. R. L., Leite, N. C., Moram, C. B. M., & Salles, G. F. (2018). Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-018-0677-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.